Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Presenter: Jaya Batra

March 03, 2026

Presentation THT 2026

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Presenter: Nicolas M. Van Mieghem

March 03, 2026

Presentation THT 2026

Exercise-Induced MR: Implications for Diagnosis and Treatment

Presenter: Nikhil Narang

March 03, 2026

Presentation THT 2026

Medical Therapy for TR

Presenter: Sean P. Pinney

March 03, 2026

Presentation THT 2026

Anatomic Considerations for T-TEER and TTVR

Presenter: Jörg Hausleiter

March 03, 2026

Presentation THT 2026

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Jena-VAD Trial Updates and Lessons Learned

Presenter: Gabriel Sayer

March 03, 2026

Presentation THT 2026

Case Presentation of LVAD-AR JenaValve Implantation (Prerecorded Live Case)

Presenter: Torsten P. Vahl

March 03, 2026

Presentation THT 2026

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Presenter: Michael I. Brener

March 03, 2026

Presentation THT 2026

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mark Darkwah

March 03, 2026

Presentation THT 2026

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Presenter: Neal Patel

March 03, 2026

Presentation THT 2026

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

Presenter: Frailyn J. Nunez

March 03, 2026

Presentation THT 2026

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Presenter: Mia Papas

March 03, 2026

Presentation THT 2026

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Presenter: Matthew Ramm

March 03, 2026

Presentation THT 2026

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Presenter: Edwin Ho

March 03, 2026

Presentation THT 2026

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Presenter: Akshay Arora

March 03, 2026

Presentation THT 2026

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Presenter: Hanna Gaggin

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Advertisement

Debate: A Patient With MR Not Improving With GDMT: Go to VAD

Debate: A Patient With MR Not Improving With GDMT: Try mTEER

Cardiomechanics Before and After mTEER: Insights From Pressure-Volume Analysis

Exercise-Induced MR: Implications for Diagnosis and Treatment

Medical Therapy for TR

Anatomic Considerations for T-TEER and TTVR

An Emerging Problem: TR in Advanced Heart Failure (LVAD, OHT) Patients

Jena-VAD Trial Updates and Lessons Learned

Case Presentation of LVAD-AR JenaValve Implantation (Prerecorded Live Case)

Preclinical Results of a Novel, Percutaneous Device to Reapproximate and Reshape the Right Ventricle in Functional Tricuspid Regurgitation with Right Ventricular Dysfunction

Impact of Left Atrial Appendage Closure on Clinical Outcomes In Patients with Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

Heart Failure Phenotype and Peri-Procedural Cardioversion After TEER: A National Inpatient Analysis

Echocardiographic Assessment of Pulmonary Vascular Resistance Changes and Clinical Outcomes Following Transcatheter Mitral Valve Edge-to-Edge Repair

Treatment patterns among mixed phenotype transthyretin amyloidosis patients: A real-world multinational survey

Development of Cardiomyopathy in Patients with ADHD Treated with Stimulants, Nonstimulants, and No Pharmacotherapy

Early Human Feasibility Experience with a Novel Transcatheter Cardiac Leaflet Enhancer (CARLEN) to Treat Functional Mitral Regurgitation in Heart Failure reduced Ejection Fraction

Automated 99mTechnetium-Pyrophosphate Planar Scintigraphy Interpretation From Clinical Imaging PDFs Using a Vision-Enabled Reasoning Large Language Models

Characteristics associated with disease progression in patients with transthyretin amyloid cardiomyopathy treated with tafamidis

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content